Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Jul;94(Pt 7):1451-1461.
doi: 10.1099/vir.0.053124-0. Epub 2013 Apr 11.

Inhibition of indoleamine 2,3-dioxygenase enhances the T-cell response to influenza virus infection

Affiliations

Inhibition of indoleamine 2,3-dioxygenase enhances the T-cell response to influenza virus infection

Julie M Fox et al. J Gen Virol. 2013 Jul.

Abstract

Influenza infection induces an increase in the level of indoleamine 2,3-dioxygenase (IDO) activity in the lung parenchyma. IDO is the first and rate-limiting step in the kynurenine pathway where tryptophan is reduced to kynurenine and other metabolites. The depletion of tryptophan, and production of associated metabolites, attenuates the immune response to infection. The impact of IDO on the primary immune response to influenza virus infection was determined using the IDO inhibitor 1-methyl-D,L-tryptophan (1MT). C57BL/6 mice treated with 1MT and infected with A/HKx31 influenza virus had increased numbers of activated and functional CD4⁺ T-cells, influenza-specific CD8⁺ T-cells and effector memory cells in the lung. Inhibition of IDO increased the Th1 response in CD4⁺ T-cells as well as enhanced the Th17 response. These studies show that inhibition of IDO engenders a more robust T-cell response to influenza virus, and suggests an approach for enhancing the immune response to influenza vaccination by facilitating increased influenza-specific T-cell response.

PubMed Disclaimer

Figures

Fig. 1.
Fig. 1.
Influenza infection increases IDO activity in the lungs and sera. Mice were treated with 1MT or control 3 days prior to infection. On day 0, i.e. 3 days after treatment, mice were intranasally (i.n.) infected with 103 p.f.u. X31 in PBS. (a) Serum and (b) lung homogenates were collected every other day from day 0 (uninfected animals) until day 14 p.i. Each time point represents the mean and sem of 3–5 mice per group and shows two independent experiments. (**P value <0.01 and *P value <0.05).
Fig. 2.
Fig. 2.
1MT treatment does not affect total frequency of T-cells infiltrating the lungs. Mice were treated with 1MT or control 3 days prior to infection and subsequently infected with 103 p.f.u. X31 i.n. (a) BAL and (b) MLN cell numbers from day 10 p.i. Number of CD8+ and CD4+ T-cells in the (c) BALs and (d) MLNs. Representative data from one experiment are shown from three independent experiments. (*P value <0.05).
Fig. 3.
Fig. 3.
1MT treatment enhances the Th1 response. Mice were treated with 1MT or control, as described, and infected with 103 p.f.u. X31 i.n. Ten days p.i., BAL cells were stimulated for 6 h with UV-inactivated influenza virus and subsequently stained for intracellular expression of IFN-γ, IL-6 and IL-4. (a) Representative dot plots of CD4+ T-cells expressing IFN-γ, IL-6 and IL-4. (b, d, f) Proportion and (c, e, g) frequency of CD4+ T-cells expressing (b, c) IFN-γ, (d, e) IL-6 and (f, g) IL-4. Representative data from one experiment are shown from three independent experiments. (**P value <0.01 and *P value <0.05).
Fig. 4.
Fig. 4.
IDO inhibition enhances the influenza-specific response. Mice were treated with 1MT or control, as described, and infected with 103 p.f.u. X31 i.n. On day 10 p.i., BAL cells were analysed for virus-specific CD8+ T-cell numbers as determined by tetramers specific to NP366–374, PA224–233 or PB1703–711. (a) Proportion and (b) frequency of CD8+ T-cells are shown. Representative data from one experiment is shown from three independent experiments. (*P value <0.05).
Fig. 5.
Fig. 5.
IDO inhibition increases the frequency of functional PA-specific CD8+ T-cells. Mice were treated with 1MT or control, as described, and infected with 103 p.f.u. X31 i.n. Ten days p.i., single cells from the BALs were stimulated for 4 h with influenza immunodominant peptides and subsequently stained for intracellular expression of IFN-γ. (a, b) Representative dot plots of (a) CD8+ T-cells and (b) influenza-specific CD8+ T-cells expressing IFN-γ. (c) Percentage and (d) frequency of CD8+ T-cells expressing IFN-γ. (e) Percentage and (f) frequency of influenza-specific CD8+ T-cells expressing IFN-γ. Representative data from one experiment are shown from three independent experiments. (*P value <0.05).
Fig. 6.
Fig. 6.
Inhibition of IDO activity increases the presence of CD8+ effector memory cells. Mice were treated with 1MT or control 3 days prior to infection. On day 0, mice were i.n. infected with 103 p.f.u. X31. (a, b) CD8+ and (c, d) CD4+ T-cells collected 10 days p.i. from the BALs were stained for the presence of CD44 and CD62L. Representative data from one experiment is shown from two independent experiments. (*P value <0.05).

Similar articles

Cited by

References

    1. Andersson J., Boasso A., Nilsson J., Zhang R., Shire N. J., Lindback S., Shearer G. M., Chougnet C. A. (2005). The prevalence of regulatory T cells in lymphoid tissue is correlated with viral load in HIV-infected patients. J Immunol 174, 3143–3147 - PubMed
    1. Baban B., Chandler P. R., Sharma M. D., Pihkala J., Koni P. A., Munn D. H., Mellor A. L. (2009). IDO activates regulatory T cells and blocks their conversion into Th17-like T cells. J Immunol 183, 2475–2483 10.4049/jimmunol.0900986 - DOI - PMC - PubMed
    1. Baban B., Chandler P. R., Johnson B. A., III, Huang L., Li M., Sharpe M. L., Francisco L. M., Sharpe A. H., Blazar B. R. & other authors (2011). Physiologic control of IDO competence in splenic dendritic cells. J Immunol 187, 2329–2335 10.4049/jimmunol.1100276 - DOI - PMC - PubMed
    1. Bianchi M., Bertini R., Ghezzi P. (1988). Induction of indoleamine dioxygenase by interferon in mice: a study with different recombinant interferons and various cytokines. Biochem Biophys Res Commun 152, 237–242 10.1016/S0006-291X(88)80705-8 - DOI - PubMed
    1. Boasso A., Herbeuval J. P., Hardy A. W., Anderson S. A., Dolan M. J., Fuchs D., Shearer G. M. (2007). HIV inhibits CD4+ T-cell proliferation by inducing indoleamine 2,3-dioxygenase in plasmacytoid dendritic cells. Blood 109, 3351–3359 10.1182/blood-2006-07-034785 - DOI - PMC - PubMed

Publication types

MeSH terms